Blog
RSS FeedPosted by Michael Wonder on 30 Apr 2020
TGA publishes more information about medicine formulations
30 April 2020 - To improve access to important medicine information, the Therapeutic Goods Administration now publishes additional formulation details ...
Posted by Michael Wonder on 08 Apr 2020
Submissions on whether the TGA should publish that a prescription medicine is under evaluation
8 April 2020 - Between 15 February and 29 March 2019, the TGA sought comments from interested parties on the ...
Posted by Michael Wonder on 31 Mar 2020
1 April 2020 price disclosure confirmed prices
31 March 2020 - Confirmed 1 April 2020 prices resulting from the 2020 April cycle of price disclosure have been published ...
Posted by Michael Wonder on 05 Mar 2020
Standardised redactions to Public Summary Documents – nominations open for participation in the final trial, and implementation from July 2020
5 March 2020 - The Department is now seeking nominations from sponsors with submissions due to be considered at the ...
Posted by Michael Wonder on 24 Feb 2020
FDA launches new Purple Book searchable database to help patients and prescribers identify FDA-approved biologic and biosimilar treatment options
24 February 2020 - Today, the FDA is releasing the first phase of the enhancement of the “Purple Book: Database of ...
Posted by Michael Wonder on 03 Feb 2020
2020 April price disclosure cycle - indicative prices
3 February 2020 - Indicative 1 April 2020 prices resulting from the 2020 April Cycle of Price Disclosure have now been ...
Posted by Michael Wonder on 29 Jan 2020
Documents disclosed to the EMA as part of an MA application process are not presumed to be confidential
28 January 2020 - On 22 January 2020 the CJEU handed down two decisions in which it decided that the ...
Posted by Michael Wonder on 22 Jan 2020
Court of Justice upholds EMA’s approach to transparency
22 January 2020 - EMA welcomes today’s two appellate judgments by the Court of Justice that confirmed, in clear and ...
Posted by Michael Wonder on 20 Jan 2020
Talkin’ about a resolution: issues in the push for greater transparency of medicine prices
20 January 2020 - At the 2019 World Health Assembly, a significant new resolution was agreed by most countries to start ...
Posted by Michael Wonder on 10 Jan 2020
Defending transparency at European drug regulator
8 January 2020 - Forthcoming judgment must uphold public access to clinical data ...
Posted by Michael Wonder on 18 Dec 2019
Price disclosure 2020 April cycle outcomes summary
18 December 2019 - The summary of price disclosure price reductions for the 2020 April Cycle has now been published. ...
Posted by Michael Wonder on 05 Dec 2019
Hospital groups sue to block price transparency rule
4 December 2019 - Health care providers say disclosure requirement pushed by Trump violates First Amendment. ...
Posted by Michael Wonder on 27 Nov 2019
How to navigate specialist fees in the private health system
26 November 2019 - Have you ever taken up private health insurance, only to end up hundreds or thousands of ...
Posted by Michael Wonder on 21 Nov 2019
Transparency is a first step in bringing down drug costs for American seniors, families
21 November 2019 - Wherever I go — be it to school events, county fairs, town halls, or even the ...
Posted by Michael Wonder on 18 Nov 2019
To lower costs, Trump to force hospitals to reveal price of care
15 November 2019 - The Trump administration on Friday announced it would begin forcing hospitals to publicly disclose the discounted ...